57 results
8-K
EX-10.2
nebjf
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
SC 14D9
EX-99
43biwow83iv otw1
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
vrt4ihwl
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
EX-99
4p7 141cc75y0
6 Jun 22
Third party tender offer statement
5:02pm
8-K
EX-2.1
umng70y
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
2e51tgl3
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
S-8
EX-10.1
d8d 87645
15 Oct 21
Registration of securities for employees
5:01pm
8-K
ts5muzyx hqigawk46
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm
8-K
EX-10.1
ka4haucxb 0nj52qqt
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm
8-K
EX-10.1
f5vfv8bmnc gud
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-10.2
h0q0gq px63
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-10.3
pvbd 6hxei5vu
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm